Palred Technologies: Results for the quarter and Half year ended 30.09.2026
Palred Technologies (PALREDTEC) filed a disclosure titled "Results for the quarter and Half year ended 30.09.2026". The company is valued at about ₹59.69 crore.
What happened
Palred Technologies (PALREDTEC) filed a disclosure with the exchanges on 13 November 2026 at 03:41 PM titled "Results for the quarter and Half year ended 30.09.2026".
Company snapshot
Palred Technologies is a micro-cap company, with a market value of about ₹59.69 crore.
The stock last traded at ₹48.8, against a 52-week range of ₹27.45–₹60.2 (18.9% below the high).
Before this filing the shares had moved +5.3% over the month and −5.5% over three months. Average daily turnover over the last 20 sessions was about ₹0.02 crore.
Promoters held 30.13% at the end of Q1 FY27.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 14 | -2.5 | -2.07 |
| Q2 FY26 | 24 | -0.9 | -0.74 |
| Q3 FY26 | 18 | -1 | -0.82 |
| Q4 FY26 | 22 | -0.8 | -0.67 |
| Q1 FY27 | 22 | -1 | -0.78 |
What history shows
BCEIE's records show 2 previous results filings from the company since May 2026.
After those filings, the stock gained 2.1% on average the next trading day and was up 3.8% on average after five days (2 filings with price data).
Market-wide, 11,743 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 43% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 13 Aug 2026 | , the financial results for the period ended Jun 30, 2026. | +3.4% | +8.3% |
| 29 May 2026 | , the financial results for the period ended March 31, 2026. | +0.7% | −0.7% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 13 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.